Eriodictyol
CAS No. 552-58-9
Eriodictyol ( Huazhongilexone )
Catalog No. M18795 CAS No. 552-58-9
1. Eriodictyol is a flavonoid with anti-inflammatory and antioxidant activities.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 58 | In Stock |
|
10MG | 84 | In Stock |
|
25MG | 138 | In Stock |
|
50MG | 206 | In Stock |
|
100MG | 308 | In Stock |
|
500MG | 732 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEriodictyol
-
NoteResearch use only, not for human use.
-
Brief Description1. Eriodictyol is a flavonoid with anti-inflammatory and antioxidant activities.
-
DescriptionEriodictyol is a flavonoid with anti-inflammatory and antioxidant activities. Eriodictyol may possess antidiabetic properties through increasing glucose uptake and improving insulin resistance. Eriodictyol may be a potential therapeutic resource for Atopic dermatitis and an adjunctive agent to control itchiness inAtopic dermatitis.
-
SynonymsHuazhongilexone
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number552-58-9
-
Formula Weight288.25
-
Molecular FormulaC15H12O6
-
Purity98%
-
SolubilityDMSO : 155 mg/mL 537.73 mM;
-
SMILESC1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC(=C(C=C3)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
5,8-Epidioxyergosta-...
9,11-Dehydroergosterol peroxide is a useful organic compound for research related to life sciences.
-
Runcaciguat
Runcaciguat is a soluble guanylate cyclase stimulator. Runcaciguat combines with selective partial adenosine A1 receptor agonists and can be used in studies about cardiovascular and renal diseases.
-
GSK2807 Trifluoroace...
GSK2807 Trifluoroacetate is a selective and SAM-competitive inhibitor of SMYD3 (Ki: 14 nM; IC50: 130 nM).GSK2807, a potent and selective, SAM-competitive inhibitor of SMYD3 (Ki = 14 nM).?A high-resolution crystal structure reveals that GSK2807 bridges the gap between the SAM-binding pocket and the substrate lysine tunnel of SMYD3.